1: Lange F, Pfennigwerth N, Höfken LM, Gatermann SG, Kaase M. Characterization of mutations in Escherichia coli PBP2 leading to increased carbapenem MICs. J Antimicrob Chemother. 2018 Nov 27. doi: 10.1093/jac/dky476. [Epub ahead of print] PubMed PMID: 30496417.
2: Rohs PDA, Buss J, Sim SI, Squyres GR, Srisuknimit V, Smith M, Cho H, Sjodt M, Kruse AC, Garner EC, Walker S, Kahne DE, Bernhardt TG. A central role for PBP2 in the activation of peptidoglycan polymerization by the bacterial cell elongation machinery. PLoS Genet. 2018 Oct 18;14(10):e1007726. doi: 10.1371/journal.pgen.1007726. eCollection 2018 Oct. PubMed PMID: 30335755; PubMed Central PMCID: PMC6207328.
3: Thakur SD, Levett PN, Horsman GB, Dillon JR. Association of Neisseria gonorrhoeae genogroups and specific PBP2/MtrR/PorB mutation patterns with susceptibility to penicillin in a susceptible gonococcal population. J Antimicrob Chemother. 2018 Oct 1;73(10):2682-2686. doi: 10.1093/jac/dky233. PubMed PMID: 29992304.
4: Ábrók M, Lázár A, Szécsényi M, Deák J, Urbán E. Combination of MALDI-TOF MS and PBP2' latex agglutination assay for rapid MRSA detection. J Microbiol Methods. 2018 Jan;144:122-124. doi: 10.1016/j.mimet.2017.11.021. Epub 2017 Nov 24. PubMed PMID: 29180272.
5: Contreras-Martel C, Martins A, Ecobichon C, Trindade DM, Matteï PJ, Hicham S, Hardouin P, Ghachi ME, Boneca IG, Dessen A. Molecular architecture of the PBP2-MreC core bacterial cell wall synthesis complex. Nat Commun. 2017 Oct 3;8(1):776. doi: 10.1038/s41467-017-00783-2. PubMed PMID: 28974686; PubMed Central PMCID: PMC5626683.
6: Ferrer-González E, Kaul M, Parhi AK, LaVoie EJ, Pilch DS. β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00863-17. doi: 10.1128/AAC.00863-17. Print 2017 Sep. PubMed PMID: 28630190; PubMed Central PMCID: PMC5571351.
7: Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA, Oliver A. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones. Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02529-16. doi: 10.1128/AAC.02529-16. Print 2017 Jun. PubMed PMID: 28289035; PubMed Central PMCID: PMC5444176.
8: Doumith M, Mushtaq S, Livermore DM, Woodford N. New insights into the regulatory pathways associated with the activation of the stringent response in bacterial resistance to the PBP2-targeted antibiotics, mecillinam and OP0595/RG6080. J Antimicrob Chemother. 2016 Oct;71(10):2810-4. doi: 10.1093/jac/dkw230. Epub 2016 Jun 20. PubMed PMID: 27330062.
9: Aissa N, Mayer N, Bert F, Labia R, Lozniewski A, Nicolas-Chanoine MH. A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain. J Antimicrob Chemother. 2016 Jan;71(1):76-9. doi: 10.1093/jac/dkv318. Epub 2015 Oct 12. PubMed PMID: 26462991.
10: Ladwig N, Franz-Wachtel M, Hezel F, Soufi B, Macek B, Wohlleben W, Muth G. Control of Morphological Differentiation of Streptomyces coelicolor A3(2) by Phosphorylation of MreC and PBP2. PLoS One. 2015 Apr 30;10(4):e0125425. doi: 10.1371/journal.pone.0125425. eCollection 2015. PubMed PMID: 25927987; PubMed Central PMCID: PMC4416010.